开云app官网登录入口网页版-官方正版

#A型血#

48篇内容 | 1823人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1678166, encodeId=453916e8166bf, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=美国学者最新分析指出：A型血人易早发中风，O型血最安全！, objectType=article, longId=737643, objectId=c91de3764331, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c91de3764331, replyNumber=0, likeNumber=77, createdTime=2023-05-20, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c91de3764331, moduleTitle=美国学者最新分析指出：A型血人易早发中风，O型血最安全！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c91de3764331)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678165, encodeId=3fc616e8165cb, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=经先前治疗的严重A型血友病该如何治疗？efanesoctocog alpha在临床试验中已达到主要终点, objectType=article, longId=300734, objectId=5e00300e34a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e00300e34a5, replyNumber=0, likeNumber=107, createdTime=2022-11-08, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e00300e34a5, moduleTitle=经先前治疗的严重A型血友病该如何治疗？efanesoctocog alpha在临床试验中已达到主要终点, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5e00300e34a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678164, encodeId=bd9216e816410, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=NEJM：SPK-8011基因疗法治疗A型血友病, objectType=article, longId=220584, objectId=02cf220584b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02cf220584b4, replyNumber=0, likeNumber=84, createdTime=2022-06-09, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02cf220584b4, moduleTitle=NEJM：SPK-8011基因疗法治疗A型血友病, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=02cf220584b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678163, encodeId=6b8716e816301, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=HAEMOPHILIA：A型血友病患者对固定剂量预防N8-GP的长期反应的事后分析, objectType=article, longId=217991, objectId=dcbe21e99153, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dcbe21e99153, replyNumber=0, likeNumber=85, createdTime=2021-10-11, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dcbe21e99153, moduleTitle=HAEMOPHILIA：A型血友病患者对固定剂量预防N8-GP的长期反应的事后分析, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=dcbe21e99153)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678161, encodeId=91bb16e8161c0, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=Blood：艾米珠单抗预防用于A型血友病患者的长期疗效, objectType=article, longId=210677, objectId=b92d2106e75e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b92d2106e75e, replyNumber=0, likeNumber=106, createdTime=2022-03-17, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b92d2106e75e, moduleTitle=Blood：艾米珠单抗预防用于A型血友病患者的长期疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b92d2106e75e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678160, encodeId=c31d16e81603d, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=A型血友病，Efanesoctocog alfa被FDA授予“快速通道资格”, objectType=article, longId=207423, objectId=044820e4234d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=044820e4234d, replyNumber=0, likeNumber=69, createdTime=2022-01-06, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=044820e4234d, moduleTitle=A型血友病，Efanesoctocog alfa被FDA授予“快速通道资格”, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=044820e4234d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678162, encodeId=be3e16e816221, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=罗氏重磅新药舒友立乐®在华斩获新适应症，助力更多A型血友病患者迈向“零出血”自由人生, objectType=article, longId=210711, objectId=8b33210e118c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b33210e118c, replyNumber=0, likeNumber=91, createdTime=2021-07-18, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b33210e118c, moduleTitle=罗氏重磅新药舒友立乐®在华斩获新适应症，助力更多A型血友病患者迈向“零出血”自由人生, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8b33210e118c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678158, encodeId=090b16e8158ff, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=NEJM：BIVV001可维持严重A型血友病患者长期较高水平的VIII因子活性, objectType=article, longId=200530, objectId=6ba320053036, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ba320053036, replyNumber=0, likeNumber=81, createdTime=2021-04-22, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ba320053036, moduleTitle=NEJM：BIVV001可维持严重A型血友病患者长期较高水平的VIII因子活性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6ba320053036)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678156, encodeId=032c16e8156cd, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=WFH 2020：四年数据显示，A型血友病基因疗法valoctocogene roxaparvovec可持续减少出血, objectType=article, longId=196108, objectId=e997196108f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e997196108f4, replyNumber=0, likeNumber=101, createdTime=2020-09-14, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e997196108f4, moduleTitle=WFH 2020：四年数据显示，A型血友病基因疗法valoctocogene roxaparvovec可持续减少出血, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e997196108f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678157, encodeId=ffda16e815747, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=NEJM：全基因组关联研究发现重症COVID-19遗传易感基因，且A型血感染者更易呼吸衰竭, objectType=article, longId=196427, objectId=ca2b19642e6c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca2b19642e6c, replyNumber=0, likeNumber=72, createdTime=2020-12-05, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca2b19642e6c, moduleTitle=NEJM：全基因组关联研究发现重症COVID-19遗传易感基因，且A型血感染者更易呼吸衰竭, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ca2b19642e6c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678159, encodeId=4d4d16e81594b, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=Blood：重组FVIII药物Rurioctocog alfa pegol预防性治疗A型血友病, objectType=article, longId=203528, objectId=9b0d20352851, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b0d20352851, replyNumber=0, likeNumber=97, createdTime=2021-10-10, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b0d20352851, moduleTitle=Blood：重组FVIII药物Rurioctocog alfa pegol预防性治疗A型血友病, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9b0d20352851)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678154, encodeId=d90816e81542d, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=medRxiv: A型血更容易感染，O型血风险更低, objectType=article, longId=190322, objectId=4d6219032295, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d6219032295, replyNumber=0, likeNumber=76, createdTime=2020-06-12, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d6219032295, moduleTitle=medRxiv: A型血更容易感染，O型血风险更低, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4d6219032295)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678155, encodeId=fb7516e81553f, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=medRxiv： A型血人是新冠病毒的“软柿子”？专家剖析其可信度有多大, objectType=article, longId=190451, objectId=7bb21904519b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bb21904519b, replyNumber=0, likeNumber=77, createdTime=2021-02-04, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bb21904519b, moduleTitle=medRxiv： A型血人是新冠病毒的“软柿子”？专家剖析其可信度有多大, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7bb21904519b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678152, encodeId=73a516e81526b, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=Blood：BIVV001，一种新型FVIII替代品，用于A型血友病的止血控制效果！, objectType=article, longId=188541, objectId=803f18854179, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=803f18854179, replyNumber=0, likeNumber=75, createdTime=2020-05-05, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=803f18854179, moduleTitle=Blood：BIVV001，一种新型FVIII替代品，用于A型血友病的止血控制效果！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=803f18854179)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678151, encodeId=b15916e81514a, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=BioMarin计划为其A型血友病基因疗法Valrox，定价为200万至300万美元, objectType=article, longId=186519, objectId=e25f18651951, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e25f18651951, replyNumber=0, likeNumber=94, createdTime=2020-10-28, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e25f18651951, moduleTitle=BioMarin计划为其A型血友病基因疗法Valrox，定价为200万至300万美元, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e25f18651951)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678150, encodeId=8ea916e815025, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=NEJM：AAV5-hFVIII-SQ基因疗法治疗A型血友病, objectType=article, longId=185592, objectId=01b9185592c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01b9185592c1, replyNumber=0, likeNumber=78, createdTime=2020-05-03, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01b9185592c1, moduleTitle=NEJM：AAV5-hFVIII-SQ基因疗法治疗A型血友病, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=01b9185592c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678148, encodeId=1b1a16e8148c1, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=A型血友病治疗前沿：SubQ-8（一种新型重组FVIII）的新近进展, objectType=article, longId=175027, objectId=56af1e502778, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56af1e502778, replyNumber=0, likeNumber=84, createdTime=2020-04-29, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56af1e502778, moduleTitle=A型血友病治疗前沿：SubQ-8（一种新型重组FVIII）的新近进展, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=56af1e502778)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678149, encodeId=fb3416e814923, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=Blood：Emicizumab预防用于儿童A型血友病, objectType=article, longId=181209, objectId=7d9b18120992, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d9b18120992, replyNumber=0, likeNumber=78, createdTime=2020-02-01, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d9b18120992, moduleTitle=Blood：Emicizumab预防用于儿童A型血友病, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7d9b18120992)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678153, encodeId=8f6c16e815367, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=Medrxiv：新冠病毒易感与血型有关？A型血更易感，O型血风险较低, objectType=article, longId=190218, objectId=846019021880, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=846019021880, replyNumber=0, likeNumber=79, createdTime=2020-12-03, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=846019021880, moduleTitle=Medrxiv：新冠病毒易感与血型有关？A型血更易感，O型血风险较低, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=846019021880)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678144, encodeId=625f16e814475, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, objectTitle=血型竟然也能被改变？UBC科学家将A型血转化为“万能血液”, objectType=article, longId=168395, objectId=9e351683952d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e351683952d, replyNumber=0, likeNumber=76, createdTime=2019-08-22, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e351683952d, moduleTitle=血型竟然也能被改变？UBC科学家将A型血转化为“万能血液”, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9e351683952d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

A型血

2020-05-29

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

美国学者最新分析指出：A型血人易早发中风，O型血最安全！

2023-05-20

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

经先前治疗的严重A型血友病该如何治疗？efanesoctocog alpha在临床试验中已达到主要终点

2022-11-08

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

NEJM：SPK-8011基因疗法治疗A型血友病

2022-06-09

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

HAEMOPHILIA：A型血友病患者对固定剂量预防N8-GP的长期反应的事后分析

2021-10-11

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

Blood：艾米珠单抗预防用于A型血友病患者的长期疗效

2022-03-17

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

A型血友病，Efanesoctocog alfa被FDA授予“快速通道资格”

2022-01-06

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

罗氏重磅新药舒友立乐®在华斩获新适应症，助力更多A型血友病患者迈向“零出血”自由人生

2021-07-18

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

NEJM：BIVV001可维持严重A型血友病患者长期较高水平的VIII因子活性

2021-04-22

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

WFH 2020：四年数据显示，A型血友病基因疗法valoctocogene roxaparvovec可持续减少出血

2020-09-14

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

NEJM：全基因组关联研究发现重症COVID-19遗传易感基因，且A型血感染者更易呼吸衰竭

2020-12-05

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

Blood：重组FVIII药物Rurioctocog alfa pegol预防性治疗A型血友病

2021-10-10

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

medRxiv: A型血更容易感染，O型血风险更低

2020-06-12

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

medRxiv： A型血人是新冠病毒的“软柿子”？专家剖析其可信度有多大

2021-02-04

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

Blood：BIVV001，一种新型FVIII替代品，用于A型血友病的止血控制效果！

2020-05-05

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

BioMarin计划为其A型血友病基因疗法Valrox，定价为200万至300万美元

2020-10-28

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

NEJM：AAV5-hFVIII-SQ基因疗法治疗A型血友病

2020-05-03

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

A型血友病治疗前沿：SubQ-8（一种新型重组FVIII）的新近进展

2020-04-29

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

Blood：Emicizumab预防用于儿童A型血友病

2020-02-01

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

Medrxiv：新冠病毒易感与血型有关？A型血更易感，O型血风险较低

2020-12-03

仁者大医 (审核中...)

前往app查看评论内容

#A型血#

血型竟然也能被改变？UBC科学家将A型血转化为“万能血液”

2019-08-22

科室
- - 订阅+
  - 更多科室
工具
服务